New hope for catheter patients: expanded access to Infection-Fighting drug DefenCath
Prevention
NO_LONGER_AVAILABLE
This expanded access program offers DefenCath, a catheter lock solution containing taurolidine and heparin, to adult and pediatric patients who need a catheter but cannot join ongoing clinical trials or do not meet the current FDA-approved label. The goal is to prevent central li…
Sponsor: CorMedix • Aim: Prevention
Last updated Jul 02, 2026 13:01 UTC